Ethos.AI
AgenticAI-driven platform reimagining preventive and insurance policy-based medical screenings
Platform · Cloud SaaSCompany source
Company profile
About Cardiotrack
Cardiotrack is a pioneering health-tech company that is redefining preventive and insurance policy-based medical screenings through its advanced AgenticAI-driven platform, Ethos.AI. The company has built an extensive network of over 1,600 diagnostic labs across more than 600 cities, providing 80% population reach across its markets. Cardiotrack has transformed the at-home health screening landscape by enabling complex diagnostic tests such as ECGs and stress tests (equivalent to treadmill tests) to be conducted in patients' homes. The company's end-to-end automation platform ensures faster case closures, reduces discrepancies, and delivers an exceptional customer experience. With over 400,000 individuals screened and partnerships with more than 10 insurance customers, Cardiotrack serves insurers, corporates, diagnostic labs, and individuals seeking comprehensive health checkups. The platform integrates data analytics, process automation, support automation, report quality checks, and tele-ECG capabilities to streamline the entire health screening workflow. Cardiotrack is trusted by leading insurers for delivering reliable, technology-enabled preventive health screening solutions.
Company description Cardiotrack official website
Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Cardiotrack?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiovascular health
- General preventive screening
Who it serves
- Corporates
- Diagnostic Labs
- Individual consumers
- Insurers
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Geographic context
MarketsIndia (600+ cities with 80% population reach)
Company sourceOfficial website
Company milestones
Platform expansion
Expanded to 1,600+ lab network across 600+ cities; introduced at-home stress ECG testing equivalent to treadmill tests; added advanced radiology tests to at-home screening portfolio
Partnerships
Recorded partners
- 1,600+ diagnostic labs
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Stress ECG at Home
At-home stress testing equivalent to traditional treadmill tests
Service · HybridCompany source
Tele ECG
Remote ECG testing and monitoring solution for at-home health screenings
Service · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
400,000+ individuals screened
Total screening volume
Faster closures
Case processing efficiency
Fewer discrepancies
Quality improvement through automation
Leading Insurers (10+ Insurance Customers)
Preventive and insurance policy-based medical screenings with at-home health screening services
400,000+ individuals screened across 600+ cities with faster closures and fewer discrepancies
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Avin Agarwal
Author/Team Member
06 · Company updates
Updates from Cardiotrack
Recent articles published on Cardiotrack's official website.
Why a paper ECG cannot be risk scored, and what structured ECG data changes
Read on CardiotrackHow Cardiotrack Health Screening Works
Read on CardiotrackCardiotrack Ethos.AI Transforming At-Home Health Screening with Advanced Radiology Tests
Read on CardiotrackHow to choose an ECG machine for your clinic in India, a practical buyer guide
Read on Cardiotrack07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Cardiology & Cardiovascular Health
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.